Key Metrics
Q4
Oncology
SJR
- Q4 Oncology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
Indexed in the following public directories
-
Scopus
Planning to publish in Revisiones en Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Role of FDG-PET/CT in diagnosis and follow-up head and neck cancer
- 1 Jan 24
- Revisiones en Cáncer
-
Full paper
Role of radiotherapy in early head and neck cancer
- 1 Jan 24
- Revisiones en Cáncer
-
Full paper
Complications prevention of bone metastases in prostate cancer
- 1 Jan 24
- Revisiones en Cáncer
-
Full paper
Radiotherapy in prostatic cancer
- 1 Jan 24
- Revisiones en Cáncer
-
Full paper
Head and neck carcinoma in patients not eligible for platinum
- 1 Jan 24
- Revisiones en Cáncer
-
Full paper
Role of radiotherapy and re-irradiation in recurrence and metastatic disease
- 1 Jan 24
- Revisiones en Cáncer
FAQs
How many articles did Revisiones en Cancer publish last years ?
In 2023, Revisiones en Cancer published 24 articles.
What is the SJR for Revisiones en Cancer ?
SJR for Revisiones en Cancer is Q4.
Who is the publisher of Revisiones en Cancer ?
Aran Ediciones SA is the publisher of Revisiones en Cancer.